KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
Drug Topics articles
- <![CDATA[Fremanezumab Reduces Monthly Migraine Days for Pediatric Patients]]> January 17, 2026
- <![CDATA[Pennsylvania Pharmacy Association: Promoting the Profession to Enhance Patient Care]]> January 16, 2026
- <![CDATA[Gestational Diabetes Increases Risk of Worse Postpartum Cardiovascular Health]]> January 16, 2026
- <![CDATA[Trump Administration Lays Out Great Healthcare Plan for Lower Patient Costs]]> January 16, 2026
- <![CDATA[National Pharmacist Day: Pharmacist Provider Status Reliant on Health Care Champions]]> January 15, 2026
- <![CDATA[FDA Approves Copper Histidinate Injection to Treat Menkes Disease]]> January 15, 2026
- <![CDATA[Students’ Professional Growth Relies on AI Integration in Pharmacy School Curricula]]> January 15, 2026
- <![CDATA[Strong Pharmacist Engagement Helps Patients Effectively Use OTC Products]]> January 14, 2026
- <![CDATA[Pharmacy Partner in Creating Efficiency, Profitability, and Positive Patient Outcomes]]> January 14, 2026
- <![CDATA[Time-Saving Solutions to Optimize Operations]]> January 14, 2026
Pharmacy Times articles
- <![CDATA[Oral Semaglutide Approved to Reduce the Risk of Cardiovascular Events]]> January 17, 2026
- <![CDATA[In 2026, Pharmacists Will Be Driving Change Across the Care Continuum]]> January 16, 2026
- <![CDATA[AI-Powered Digital Twins Offer a New Window Into Tumor Metabolism in Brain Cancer]]> January 16, 2026
- <![CDATA[Financial Assistance Versus Copay Accumulators: Protecting Patients from Cost Shock]]> January 16, 2026
- <![CDATA[FDA Finds No Increased Suicide Risk With GLP-1 Medications, Requests Removal of Warning Labels]]> January 16, 2026
- <![CDATA[Q&A: How Pharmacists Can Help Prevent Missed MMR Vaccinations in Children]]> January 16, 2026
- <![CDATA[Study Finds Statistically Significant Risk of Developing CKD, ESKD Following Preeclampsia]]> January 16, 2026
- <![CDATA[Q&A: Pharmacists Play Key Role as Epcoritamab Moves Into Second-Line Therapy for FL]]> January 16, 2026
- <![CDATA[Economic Instability Heightens Risk of Pediatric Long COVID]]> January 16, 2026
- <![CDATA[Hawaii Reaches Settlement With Plavix Makers Over Deceptive Labeling]]> January 16, 2026
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com
